-
The number of people who signed up for a health plan and then didn't pay their premium fell much more sharply than it has in years past. Trump officials blame fraud. Health policy experts blame costs.
-
Secretary of State Marco Rubio promised: "We have a whole-of-government response. It'll be big; it'll be fast; and it'll be effective."
-
Several hikers have died there this month, where temperatures can top 109 degrees in the shade.
-
As a culture, it’s fair to say that we are obsessed with how to look and feel younger. But what happened to aging gracefully?
-
The central issue in the Roundup case, filed by Missouri resident John Durnell, was who decides what should appear on a pesticide or insecticide label and whether a federal law overrides state claims.
-
Psychotherapist Merle Bombardieri has been helping couples with this conundrum for decades. She shares four exercises to bring clarity to the situation — and find a solution that minimizes regret.
-
A confusing patchwork of state laws began to take shape hours after the Supreme Court ruled to overturn Roe v. Wade on June 24, 2022. Here's where things stand now on the abortion issue.
-
For decades, the medical standard of care included race-based medical tests — or giving different scores to Black and white patients with identical test results — to determine how sick a patient might be.
-
Dr. Christopher Kerr put together a tool kit for the dying and their families to help them talk about the experience.
-
Drugmaker Eli Lilly and the U.S. Food and Drug Administration have granted access to retatrutide to one man, through the FDA’s so-called “compassionate use” program.
-
The Trump administration has reached a multi-state settlement with chemical giant Chemours Co. over years-long, illegal discharges of synthetic “forever chemicals” used to make products resistant to water, grease and stains. The settlement is the first by the federal government to resolve enforcement claims against a manufacturer of harmful chemicals known as PFAS.
-
NPR reports from Mongbwalu in the Democratic Republic of Congo. The fight to contain the virus faces obstacles from lack of supplies to residents who doubt that the virus is real.